![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 44, 29002-29008, October 30, 1998
From the Considerable progress has been made in the
understanding of tumor necrosis factor (TNF) signaling; however, the
molecular and biochemical basis of tumor resistance to the cytotoxic
action of TNF are still not definitively identified yet. Although a
role of c-Jun N-terminal kinase (JNK) pathway has been suggested as an
effector in TNF signaling, its exact relative contribution and its
interaction with ceramide pathway and tumor resistance to TNF remain
unknown. The relationship between JNK activation and human breast
adenocarcinoma MCF7 resistance acquisition to the cytotoxic action of
TNF was therefore investigated. We demonstrate that TNF triggers JNK
activation in both TNF-sensitive MCF7 cells and its resistant
derivative, RA1/1001. In addition, when MCF7 cells were stably
transfected with mitogen-activated protein kinase kinase 4 (MKK4)
dominant-negative cDNA or transiently transfected with a
dominant-negative c-Jun mutant (TAM 67), their susceptibility to the
cytotoxic action of TNF remains comparable with control cells. We also
demonstrated that JNK activation does not require ceramide generation
since in MCF7 cells transfected with a dominant-negative derivative of
FADD (FADD-DN), which are resistant to the cytotoxic action of TNF, TNF
induced JNK activation in the absence of ceramide generation.
Furthermore, our data indicate that exogenous permeable synthetic
ceramide C-6 induced the killing of MCF7 cells transfected with MKK4
dominant-negative cDNA. These results provide strong evidence
indicating that tumor acquisition of resistance to the cytotoxic action
of TNF may occur either independently or at a level downstream of JNK
activation and suggest that JNK activation is not linked to ceramide
pathway in TNF-mediated apoptosis.
Analysis of Human Breast Adenocarcinoma MCF7 Resistance to Tumor
Necrosis Factor-induced Cell Death
LACK OF CORRELATION BETWEEN JNK ACTIVATION AND CERAMIDE
PATHWAY
,
,
,
,
INSERM U487 Cytokines et Immunologie des
Tumeurs Humaines,
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Simstein, M. Burow, A. Parker, C. Weldon, and B. Beckman Apoptosis, Chemoresistance, and Breast Cancer: Insights From the MCF-7 Cell Model System Experimental Biology and Medicine, October 1, 2003; 228(9): 995 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Major and B. A. Wolf Interleukin-1{beta} Stimulation of c-Jun NH2-Terminal Kinase Activity in Insulin-Secreting Cells: Evidence for Cytoplasmic Restriction Diabetes, December 1, 2001; 50(12): 2721 - 2728. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Manna, N. K. Sah, and B. B. Aggarwal Protein Tyrosine Kinase p56lck Is Required for Ceramide-induced but Not Tumor Necrosis Factor-induced Activation of NF-kappa B, AP-1, JNK, and Apoptosis J. Biol. Chem., April 28, 2000; 275(18): 13297 - 13306. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Erdreich-Epstein, H. Shimada, S. Groshen, M. Liu, L. S. Metelitsa, K. S. Kim, M. F. Stins, R. C. Seeger, and D. L. Durden Integrins {{alpha}}v{beta}3 and {{alpha}}v{beta}5 Are Expressed by Endothelium of High-Risk Neuroblastoma and Their Inhibition Is Associated with Increased Endogenous Ceramide Cancer Res., February 1, 2000; 60(3): 712 - 721. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |